S Takahashi, M Colvin, J Toyosawa, M Ishida, T Kagawa, S Kuraoka, Y Aoyama, K Okamoto, I Sakakihara, K Izumikawa, K Yamamoto, S Tanaka, M Matsuura, S Ishikawa, M Wato, T Hasui, T Inaba, Journal of Crohn’s and Colitis, Volume 12, Issue supplement_1, February 2018
P442 The additional value of cytapheresis therapy in patients with severe ulcerative colitis treated with oral tacrolimus
Cytapheresis therapy as an additional therapy to oral tacrolimus is effective in patients with severe ulcerative colitis.
Successful remission of ulcerative colitis flare-up during pregnancy with adsorptive granulomonocytapheresis plus tacrolimus
Tomoyoshi Shibuya 1, Keiichi Haga 1, Masato Kamei 1, Koki Okahara 1, Shoko Ito 1, Masahito Takahashi 1, Osamu Nomura 1, Takashi Murakami 1, Masae Makino 1, Tomohiro Kodani 1, Dai Ishikawa 1, Naoto Sakamoto 1, Taro Osada 1, Tatsuo Ogihara 1, Sumio Watanabe 1, Akihito Nagahara 1 , Intest Res. 2018 Jul;16(3):484-488.
Our experience indicates that GMA, as a non-drug therapeutic intervention with a favorable safety profile, plus tacrolimus might be a relevant treatment option for patients with active IBD during pregnancy. A future study of a large cohort of pregnant patients should strengthen our findings.
Contact UsFor more informationContact Us